Perspective Therapeutics (CATX) Other Non Operating Income (2010 - 2025)
Perspective Therapeutics (CATX) reported Other Non Operating Income of $1.4 million for Q1 2025, up 70100.0% sequentially from -$2000.0 in Q4 2023.
Perspective Therapeutics (CATX) Other Non Operating Income (2010 - 2025) Analysis & Trends
Perspective Therapeutics (CATX) has 12 years of Other Non Operating Income data on file, last reported at $1.4 million in Q1 2025.
- For the quarter ending Q1 2025, Other Non Operating Income changed N/A year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (changed 0.14% YoY), and the FY2025 full-year result was $1.4 million, changed N/A from the prior year.
- Other Non Operating Income advanced to $1.4 million in Q1 2025, from -$2000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.4 million in Q1 2025 to a low of -$2000.0 in Q4 2023.
- A 3-year average of $365500.0 and a median of $32000.0 in 2022 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 103.23% in 2023, while the deepest fall reached 103.23% in 2023.
- Tracing CATX's Other Non Operating Income over 3 years: stood at $62000.0 in 2022, then plunged by 103.23% to -$2000.0 in 2023, then surged by 70100.0% to $1.4 million in 2025.
- Business Quant data shows CATX's Other Non Operating Income at $1.4 million in Q1 2025, -$2000.0 in Q4 2023, and $2000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2023 | -2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Dec 31, 2022 | 62,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Jun 30, 2017 | 7,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Jun 30, 2016 | 18,000.00 |
| Mar 31, 2016 | 78,000.00 |
| Jun 30, 2015 | -605.00 |
| Mar 31, 2015 | 28,605.00 |
| Dec 31, 2014 | 41,000.00 |
| Sep 30, 2014 | 306,000.00 |
| Jun 30, 2014 | -368,134.00 |
| Mar 31, 2014 | -1.10 Mn |
| Dec 31, 2013 | 117,000.00 |
| Sep 30, 2013 | -36,000.00 |
| Jun 30, 2013 | 25,000.00 |
| Mar 31, 2013 | 109,000.00 |
| Dec 31, 2012 | -55,000.00 |